Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2025-12-25 @ 4:43 PM
NCT ID:
NCT00871403
Group ID:
EG002
Title:
Cisplatin 75 mg/m^2 Plus Pemetrexed 500 mg/m^2
Description:
IV cisplatin 75 mg/m\^2 plus intravenous pemetrexed 500 mg/m\^2 once daily every 3 weeks for 4 or 6 cycles during the Combination Treatment Phase. Until Protocol Amendment 2, upon disease progression participants had the opportunity to receive pazopanib 800 mg monotherapy if the investigator considered it an appropriate treatment option after considering alternative options for second-line treatment.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
34
Other Number Affected:
32
Other Number At Risk:
34
Study:
NCT00871403
Results Section:
NCT00871403
Adverse Events Module:
NCT00871403